51
Views
6
CrossRef citations to date
0
Altmetric
Mini-review

Red wine and cardiovascular health the "French Paradox" revisited

, &
Pages 1-7 | Published online: 19 Jan 2010

References

  • Richard JL, Cambien F, Ducimetière P. Epidemiologic characteristics of coronary disease in France. Nouv Presse Med. 1981;10:1111–1114.
  • Renaud S, de Lorgeril M. Wine, alcohol, platelets, and the French paradox for coronary heart disease. Lancet. 1992;339:1523–1526.
  • Ruf JC, Berger JL, Renaud S. Platelet rebound effect of alcohol withdrawal and wine drinking in rats. Relation to tannins and lipid peroxidation. Arterioscler Thromb Vasc Biol. 1995;15:140–144.
  • St. Leger AS, Cochrane AL, Moore F. Factors associated with cardiac mortality in developed countries with particular reference to the consumption of wine. Lancet. 1979;1:1017–1020.
  • Di Castelnuovo A, Rotondo S, Iacoviello L, Donati MB, de Gaetano G. Meta-analysis of wine and beer consumption in relation to vascular risk. Circulation. 2002;105:2836–2844.
  • Di Castelnuovo A, Iacoviello L, de Gaetano G. Alcohol and coronary heart disease. N Engl J Med. 2003;348:1719–1722.
  • Corrao G, Bagnardi V, Zambon A, La Vecchia C. A meta-analysis of alcohol consumption and the risk of 15 diseases. Prev Med. 2004;38: 613–619.
  • Grønbaek M, Di Castelnuovo A, Iacoviello L, et al. Wine, alcohol and cardiovascular risk: open issue. J Thromb Haemost. 2004;2:2041–2048.
  • Grønbaek M, Becker U, Johansen D, et al. Type of alcohol consumed and mortality from all causes, coronary heart disease, and cancer. Ann Intern Med. 2000;133:411–419.
  • Mukamal KJ, Conigrave KM, Mittleman MA, et al. Roles of drinking pattern and type of alcohol consumed in coronary heart disease in men. N Engl J Med. 2003;348:109–118.
  • Klatsky AL, Friedman GD, Armstrong MA, Kipp H. Wine, liquor, beer, and mortality. Am J Epidemiol. 2003;158:585–595.
  • Grønbaek M. Alcohol, type of alcohol, and all-cause and coronary heart disease mortality. Ann N Y Acad Sci. 2002;957:16–20.
  • Grønbaek M, Deis A, Sørensen TI, Becker U, Schnohr P, Jensen G. Mortality associated with moderate intakes of wine, beer, or spirits. BMJ. 1995;310:1165–1169.
  • Renaud SC, Gueguen R, Siest G, Salamon R. Wine, beer, and mortality in middle-aged men from eastern France. Arch Intern Med. 1999;159: 1865–1870.
  • Thun MJ, Peto R, Lopez AD, et al. Alcohol consumption and mortality among middle-aged and elderly US adults. N Engl J Med. 1997;337: 1705–1714.
  • Djoussé L, Lee IM, Buring JE, Gaziano JM. Alcohol consumption and risk of cardiovascular disease and death in women: potential mediating mechanisms. Circulation. 2009;120:237–244.
  • Opie LH, Lecour S. The red wine hypothesis: from concepts to protective signalling molecules. Eur Heart J. 2007;28:1683–1693.
  • Di Castelnuovo A, Costanzo S, Bagnardi V, Donati MB, Iacoviello L, de Gaetano G. Alcohol dosing and total mortality in men and women. Arch Intern Med. 2006;166:2437–2445.
  • Goldberg IJ. To drink or not to drink? N Engl J Med. 2003;348:163–164.
  • van de Wiel A, de Lange DW. Cardiovascular risk is more related to drinking pattern than to the type of alcoholic drinks. Neth J Med. 2008;66:467–473.
  • Karatzi KN, Papamichael CM, Karatzis EN, et al. Red wine acutely induces favorable effects on wave reflections and central pressures in coronary artery disease patients. Am J Hypertens. 2005;18:1161–1167.
  • Papamichael C, Karatzi K, Karatzis E, et al. Combined acute effects of red wine consumption and cigarette smoking on haemodynamics of young smokers. J Hypertens. 2006;24:1287–1292.
  • Szmitko PE, Verma S. Cardiology patient pages. Red wine and your heart. Circulation. 2005;111:e10–e11.
  • Soleas GJ, Diamandis EP, Goldberg DM. Wine as a biological fluid: history, production, and role in disease prevention. J Clin Lab Anal. 1997; 11:287–313.
  • Burns J, Gardner PT, O’Neil J, et al. Relationship among antioxidant activity, vasodilation capacity, and phenolic content of red wines. J Agric Food Chem. 2000;48:220–230.
  • Mattivi F, Guzzon R, Vrhovsek U, Stefanini M, Velasco R. Metabolite profiling of grape: Flavonols and anthocyanins. J Agric Food Chem. 2006;54:7692–7702.
  • Frémont L. Biological effects of resveratrol. Life Sci. 2000;66:663–673.
  • Gambuti A, Strollo D, Ugliano M, Lecce L, Moio L. Trans-Resveratrol, quercetin, (+)-catechin, and (−)-epicatechin content in south Italian monovarietal wines: relationship with maceration time and marc pressing during winemaking. J Agric Food Chem. 2004;52:5747–5751.
  • Pellegrini N, Simonetti P, Brusamolino A, Bottasso B, Pareti FI. Composition of platelet phospholipids after moderate consumption of red wine in healthy volunteers. Eur J Clin Nutr. 1996;50:535–544.
  • Dohadwala MM, Vita JA. Grapes and cardiovascular disease. J Nutr. 2009;139:1788S–1793S.
  • Micallef M, Lexis L, Lewandowski P. Red wine consumption increases antioxidant status and decreases oxidative stress in the circulation of both young and old humans. Nutr J. 2007;6:27.
  • Tsang C, Higgins S, Duthie GG, et al. The influence of moderate red wine consumption on antioxidant status and indices of oxidative stress associated with CHD in healthy volunteers. Br J Nutr. 2005;93: 233–240.
  • Zou J, Huang Y, Chen Q, Wei E, Cao K, Wu JM. Effects of resveratrol on oxidative modification of human low density lipoprotein. Chin Med J (Engl). 2000;113:99–102.
  • Frémont L, Belguendouz L, Delpal S. Antioxidant activity of resveratrol and alcohol-free wine polyphenols related to LDL oxidation and polyunsaturated fatty acids. Life Sci. 1999;64:2511–2521.
  • Berrougui H, Grenier G, Loued S, Drouin G, Khalil A. A new insight into resveratrol as an atheroprotective compound: Inhibition of lipid peroxidation and enhancement of cholesterol efflux. Atherosclerosis. 2009;207:420–427.
  • Pearson KJ, Baur JA, Lewis KN, et al. Resveratrol delays age-related deterioration and mimics transcriptional aspects of dietary restriction without extending life span. Cell Metab. 2008;8:157–168.
  • Soleas GJ, Diamandis EP, Goldberg DM. Resveratrol: a molecule whose time has come? And gone? Clin Biochem. 1997;30:91–113.
  • Leifert WR, Abeywardena MY. Cardioprotective actions of grape polyphenols. Nutrition Res. 2008;28:729–737.
  • Das S, Santani DD, Dhalla NS. Experimental evidence for the cardioprotective effects of red wine. Exp Clin Cardiol. 2007;12:5–10.
  • Whelan AP, Sutherland WH, McCormick MP, Yeoman DJ, de Jong SA, Williams MJ. Effects of white and red wine on endothelial function in subjects with coronary artery disease. Intern Med J. 2004; 34:224–228.
  • Karatzi K, Papamichael C, Aznaouridis K, et al. Constituents of red wine other than alcohol improve endothelial function in patients with coronary artery disease. Coron Artery Dis. 2004;15:485–490.
  • Venkov CD, Myers PR, Tanner MA, Su M, Vaughan DE. Ethanol increases endothelial nitric oxide production through modulation of nitric oxide synthase expression. Thromb Haemost. 1999;81:638–642.
  • Leikert JF, Räthel TR, Wohlfart P, Cheynier V, Vollmar AM, Dirsch VM. Red wine polyphenols enhance endothelial nitric oxide synthase expression and subsequent nitric oxide release from endothelial cells. Circulation. 2002;106:1614–1617.
  • Corder R, Douthwaite JA, Lees DM, et al. Endothelin-1 synthesis reduced by red wine. Nature. 2001;414:863–864.
  • Corder R. The Wine Diet. London, UK: Sphere; 2000.
  • Pellegrini N, Pareti FI, Stabile F, Brusamolino A, Simonetti P. Effects of moderate consumption of red wine on platelet aggregation and haemostatic variables in healthy volunteers. Eur J Clin Nutr. 1996;50:209–213.
  • Pikaar NA, Wedel M, van der Beek EJ, et al. Effects of moderate alcohol consumption on platelet aggregation, fibrinolysis, and blood lipids. Metabolism. 1987;36:538–543.
  • Polagruto JA, Gross HB, Kamangar F, et al. Platelet reactivity in male smokers following the acute consumption of a flavanol-rich grapeseed extract. J Med Food. 2007;10:725–730.
  • Rimm EB, Williams P, Fosher K, Criqui M, Stampfer MJ. Moderate alcohol intake and lower risk of coronary heart disease: meta-analysis of effects on lipids and haemostatic factors. BMJ. 1999;319:1523–1528.
  • Mukamal KJ, Jadhav PP, D’Agostino RB, et al. Alcohol consumption and hemostatic factors: analysis of the Framingham Offspring cohort. Circulation. 2001;104:1367–1373.
  • Wannamethee SG, Lowe GD, Shaper G, et al. The effects of different alcoholic drinks on lipids, insulin and haemostatic and inflammatory markers in older men. Thromb Haemost. 2003;90:1080–1087.
  • Xin X, He J, Frontini MG, Ogden LG, Motsamai OI, Whelton PK. Effects of alcohol reduction on blood pressure: a meta-analysis of randomized controlled trials. Hypertension. 2001;38:1112–1117.
  • He J, Bazzano LA. Effects of lifestyle modification on treatment and prevention of hypertension. Curr Opin Nephrol Hypertens. 2000;9:267–271.
  • Keil U, Liese A, Eilipiak B, Swales JD, Grobbee DE. Alcohol, blood pressure and hypertension. Novartis Found Symp. 1998;216:125–144.
  • Beilin LJ, Puddey IB. Alcohol, hypertension and cardiovascular disease– implications for management. Clin Exp Hypertens. 1993;15:1157–1170.
  • McFadden CB, Brensinger CM, Berlin JA, Townsend RR. Systematic review of the effect of daily alcohol intake on blood pressure. Am J Hypertens. 2005;18:276–286.
  • Davies MJ, Baer DJ, Judd JT, Brown ED, Campbell WS, Taylor PR. Effects of moderate alcohol intake on fasting insulin and glucose concentrations and insulin sensitivity in postmenopausal women: a randomized controlled trial. JAMA. 2002;287:2559–2562.
  • Shai I, Wainstein J, Harman-Boehm I, et al. Glycemic effects of moderate alcohol intake among patients with type 2 diabetes: a multicenter, randomized, clinical intervention trial. Diabetes Care. 2007;30:3011–3016.
  • Sierksma A, Patel H, Ouchi N, et al. Effect of moderate alcohol consumption on adiponectin, tumor necrosis factor-alpha, and insulin sensitivity. Diabetes Care. 2004;27:184–189.
  • Djousse L, Biggs ML, Mukamal KJ, Siscovick D. Alcohol consumption and type 2 diabetes among older adults: The Cardiovascular Health Study. Obesity. 2007;15:1758–1765.
  • Brand-Miller JC, Fatema K, Middlemiss C, et al. Effect of alcoholic beverages on postprandial glycemia and insulinemia in lean, young, healthy adults. Am J Clin Nutr. 2007;85:1545–1551.
  • Joosten MM, Beulens JW, Kersten S, Hendriks HF. Moderate alcohol consumption increases insulin sensitivity and ADIPOQ expression in postmenopausal women: a randomised, crossover trial. Diabetologia. 2008;51:1375–1381.
  • Stampfer MJ, Colditz GA, Willett WC, et al. A prospective study of moderate alcohol drinking and risk of diabetes in women. Am J Epidemiol. 1988;128:549–558.
  • Koppes LL, Dekker JM, Hendriks HF, Bouter LM, Heine RJ. Moderate alcohol consumption lowers the risk of type 2 diabetes: a meta-analysis of prospective observational studies. Diabetes Care. 2005;28:719–725.
  • de Lorgeril M, Salen P, Martin JL, Boucher F, de Leiris J. Interactions of wine drinking with omega-3 fatty acids in patients with coronary heart disease: a fish-like effect of moderate wine drinking. Am Heart J. 2008;155:175–181.
  • Guiraud A, de Lorgeril M, Zeghichi S, et al. Interactions of ethanol drinking with n-3 fatty acids in rats: potential consequences for the cardiovascular system. Br J Nutr. 2008;100:1237–1244.
  • Gu X, Creasy L, Kester A, Zeece M. Capillary electrophoretic determination of resveratrol in wines. J Agric Food Chem. 1999;47: 3223–3227.
  • Celotti E, Ferrarini R, Zironi R, Conte LS. Resveratrol content of some wines obtained from dried Valpolicella grapes: Recioto and Amarone. J Chromatogr A. 1996;730:47–52.